-+ 0.00%
-+ 0.00%
-+ 0.00%

Anavex Life Sciences Q1 EPS $(0.06) Beats $(0.11) Estimate

Benzinga·02/09/2026 12:31:41
Listen to the news

Anavex Life Sciences (NASDAQ:AVXL) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.11) by 45.45 percent. This is a 57.14 percent increase over losses of $(0.14) per share from the same period last year.
Cash and cash equivalents of $131.7 million at December 31, 2025 compared to $102.6 million at September 30, 2025.